These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24100077)

  • 1. Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.
    Lacivita E; Di Pilato P; Stama ML; Colabufo NA; Berardi F; Perrone R; De Filippis B; Laviola G; Adriani W; Niso M; Leopoldo M
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6083-6. PubMed ID: 24100077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor.
    Lacivita E; Niso M; Hansen HD; Di Pilato P; Herth MM; Lehel S; Ettrup A; Montenegro L; Perrone R; Berardi F; Colabufo NA; Leopoldo M; Knudsen GM
    Bioorg Med Chem; 2014 Mar; 22(5):1736-50. PubMed ID: 24508140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
    Shimoda Y; Yui J; Xie L; Fujinaga M; Yamasaki T; Ogawa M; Nengaki N; Kumata K; Hatori A; Kawamura K; Zhang MR
    Bioorg Med Chem; 2013 Sep; 21(17):5316-22. PubMed ID: 23830697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP; Kung MP; Mu M; Kung HF
    J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
    Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
    Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.
    Lacivita E; Podlewska S; Speranza L; Niso M; Satała G; Perrone R; Perrone-Capano C; Bojarski AJ; Leopoldo M
    Eur J Med Chem; 2016 Sep; 120():363-79. PubMed ID: 27318552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
    Handzlik J; Bojarski AJ; Satała G; Kubacka M; Sadek B; Ashoor A; Siwek A; Więcek M; Kucwaj K; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2014 May; 78():324-39. PubMed ID: 24691057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Perrone R; Tortorella V
    J Pharm Pharmacol; 2004 Feb; 56(2):247-55. PubMed ID: 15005884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
    Lacivita E; De Giorgio P; Patarnello D; Niso M; Colabufo NA; Berardi F; Perrone R; Satala G; Duszynska B; Bojarski AJ; Leopoldo M
    Exp Brain Res; 2013 Oct; 230(4):569-82. PubMed ID: 23571499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
    Canale V; Guzik P; Kurczab R; Verdie P; Satała G; Kubica B; Pawłowski M; Martinez J; Subra G; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2014 May; 78():10-22. PubMed ID: 24675176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
    Fiorino F; Magli E; Severino B; Corvino A; Ciano A; Perissutti E; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2014 Oct; 347(10):698-706. PubMed ID: 25113046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.
    Ward SE; Eddershaw PJ; Scott CM; Gordon LJ; Lovell PJ; Moore SH; Smith PW; Starr KR; Thewlis KM; Watson JM
    J Med Chem; 2008 May; 51(10):2887-90. PubMed ID: 18433113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.